Conversely, TP53, STK11, and KRAS mutations were associated with worse OS in the entire cohort (Table 2); STK11 and KRAS mutations were furthermore associated with worse OS in their hallmark tumor types (NSCLC and pancreatic/colorectal, respectively; Supplementary Fig. S4C–S4E). Here, TP53 is linked to neoplasm.